Bgm BGM
NASDAQ BGM
$0.26 -0.02 (-7.52%)
As of: Aug 20, 2026 · 3:59 PM EDT

Bgm (BGM) Notes Payables (2021 - 2024)

Bgm (BGM) posted quarterly Notes Payables of $8.6 million for Q3 2024, up 36.62% year-over-year from $6.3 million in Q4 2023, and up 36.62% quarter-over-quarter from $6.3 million in Q3 2023.

Bgm (BGM) Notes Payables (2021 - 2024) Analysis & Trends

Bgm (BGM) has reported Notes Payables for 4 consecutive years, with $8.6 million the latest figure, recorded in Q3 2024.

  • In Q3 2024, Notes Payables rose 36.62% year-over-year to $8.6 million; the TTM figure through Sep 2024 stood at $8.6 million (up 36.62% YoY), while the FY2024 annual figure was $8.6 million, up 36.62% from the prior year.
  • Notes Payables grew to $8.6 million in Q3 2024 per BGM's latest filing, from $6.3 million in the prior quarter.
  • Across five years, Notes Payables topped out at $9674.8 billion in Q1 2022 and bottomed at $1.5 million in Q3 2022.
  • Historically, Notes Payables has averaged $1712.3 billion across 4 years, with a median of $8.2 million in 2021.
  • On a YoY basis, Notes Payables climbed as much as 311.33% in 2023 and fell as far as 93.81% in 2023.
  • Bgm's Notes Payables stood at $7.9 million in 2021, then plunged by 80.53% to $1.5 million in 2022, then jumped by 311.33% to $6.3 million in 2023, then jumped by 36.62% to $8.6 million in 2024.
  • Business Quant data shows BGM's Notes Payables at $8.6 million in Q3 2024, $6.3 million in Q3 2023, and $598.8 billion in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Bgm 30.61 Mn 20.79 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 8.61 Mn
Sep 30, 2023 6.30 Mn
Mar 31, 2023 598.84 Bn
Sep 30, 2022 1.53 Mn
Mar 31, 2022 9,674.85 Bn
Sep 30, 2021 7.87 Mn